Partners
The Ó³»´«Ã½ exists at the intersection of scientific disciplines, convening scientists from genomics, cell biology, chemistry, engineering, neuroscience, therapeutics, artificial intelligence/machine learning, computational biology, and public health. The Ó³»´«Ã½ engages more than 6,000 scientists from MIT, Harvard, Harvard’s teaching hospitals, academic institutions across the country, and leading industry partners including Bayer for cancer and cardiovascular health research, Boehringer Ingelheim, Calico, Deerfield Management, GSK, Novo Nordisk, and more.